BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36484504)

  • 1. Characterization of the Functional Interplay between the BRD7 and BRD9 Homologues in mSWI/SNF Complexes.
    Agbo L; Loehr J; Kougnassoukou Tchara PE; Lambert JP
    J Proteome Res; 2023 Jan; 22(1):78-90. PubMed ID: 36484504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bromodomain-containing proteins BRD1, BRD2, and BRD13 are core subunits of SWI/SNF complexes and vital for their genomic targeting in Arabidopsis.
    Yu Y; Fu W; Xu J; Lei Y; Song X; Liang Z; Zhu T; Liang Y; Hao Y; Yuan L; Li C
    Mol Plant; 2021 Jun; 14(6):888-904. PubMed ID: 33771698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy.
    Kadoch C; Hargreaves DC; Hodges C; Elias L; Ho L; Ranish J; Crabtree GR
    Nat Genet; 2013 Jun; 45(6):592-601. PubMed ID: 23644491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural Basis of Inhibitor Selectivity in the BRD7/9 Subfamily of Bromodomains.
    Karim RM; Chan A; Zhu JY; Schönbrunn E
    J Med Chem; 2020 Mar; 63(6):3227-3237. PubMed ID: 32091206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploiting epigenetic vulnerabilities in solid tumors: Novel therapeutic opportunities in the treatment of SWI/SNF-defective cancers.
    Chabanon RM; Morel D; Postel-Vinay S
    Semin Cancer Biol; 2020 Apr; 61():180-198. PubMed ID: 31568814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential Contributions of mSWI/SNF Chromatin Remodeler Sub-Families to Myoblast Differentiation.
    Padilla-Benavides T; Olea-Flores M; Sharma T; Syed SA; Witwicka H; Zuñiga-Eulogio MD; Zhang K; Navarro-Tito N; Imbalzano AN
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Interaction of SWI/SNF with the Ribosome Regulates Translation and Confers Sensitivity to Translation Pathway Inhibitors in Cancers with Complex Perturbations.
    Ulicna L; Kimmey SC; Weber CM; Allard GM; Wang A; Bui NQ; Bendall SC; Crabtree GR; Bean GR; Van Rechem C
    Cancer Res; 2022 Aug; 82(16):2829-2837. PubMed ID: 35749589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modular Organization and Assembly of SWI/SNF Family Chromatin Remodeling Complexes.
    Mashtalir N; D'Avino AR; Michel BC; Luo J; Pan J; Otto JE; Zullow HJ; McKenzie ZM; Kubiak RL; St Pierre R; Valencia AM; Poynter SJ; Cassel SH; Ranish JA; Kadoch C
    Cell; 2018 Nov; 175(5):1272-1288.e20. PubMed ID: 30343899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammalian SWI/SNF complexes in cancer: emerging therapeutic opportunities.
    St Pierre R; Kadoch C
    Curr Opin Genet Dev; 2017 Feb; 42():56-67. PubMed ID: 28391084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and functional properties of mSWI/SNF chromatin remodeling complexes revealed through single-cell perturbation screens.
    Otto JE; Ursu O; Wu AP; Winter EB; Cuoco MS; Ma S; Qian K; Michel BC; Buenrostro JD; Berger B; Regev A; Kadoch C
    Mol Cell; 2023 Apr; 83(8):1350-1367.e7. PubMed ID: 37028419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic modulation by targeting bromodomain containing protein 9 (BRD9): Its therapeutic potential and selective inhibition.
    Ali MM; Naz S; Ashraf S; Knapp S; Ul-Haq Z
    Int J Biol Macromol; 2023 Mar; 230():123428. PubMed ID: 36709803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging tools to investigate bromodomain functions.
    Kougnassoukou Tchara PE; Filippakopoulos P; Lambert JP
    Methods; 2020 Dec; 184():40-52. PubMed ID: 31726225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stepwise activities of mSWI/SNF family chromatin remodeling complexes direct T cell activation and exhaustion.
    Battistello E; Hixon KA; Comstock DE; Collings CK; Chen X; Rodriguez Hernaez J; Lee S; Cervantes KS; Hinkley MM; Ntatsoulis K; Cesarano A; Hockemeyer K; Haining WN; Witkowski MT; Qi J; Tsirigos A; Perna F; Aifantis I; Kadoch C
    Mol Cell; 2023 Apr; 83(8):1216-1236.e12. PubMed ID: 36944333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biallelic germline and somatic mutations in malignant mesothelioma: multiple mutations in transcription regulators including mSWI/SNF genes.
    Yoshikawa Y; Sato A; Tsujimura T; Otsuki T; Fukuoka K; Hasegawa S; Nakano T; Hashimoto-Tamaoki T
    Int J Cancer; 2015 Feb; 136(3):560-71. PubMed ID: 24916674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammalian SWI/SNF Chromatin Remodeling Complexes: Emerging Mechanisms and Therapeutic Strategies.
    Centore RC; Sandoval GJ; Soares LMM; Kadoch C; Chan HM
    Trends Genet; 2020 Dec; 36(12):936-950. PubMed ID: 32873422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic regulation by BAF (mSWI/SNF) chromatin remodeling complexes is indispensable for embryonic development.
    Nguyen H; Sokpor G; Pham L; Rosenbusch J; Stoykova A; Staiger JF; Tuoc T
    Cell Cycle; 2016 May; 15(10):1317-24. PubMed ID: 26986003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Bromodomains of the mammalian SWI/SNF (mSWI/SNF) ATPases Brahma (BRM) and Brahma Related Gene 1 (BRG1) promote chromatin interaction and are critical for skeletal muscle differentiation.
    Sharma T; Robinson DCL; Witwicka H; Dilworth FJ; Imbalzano AN
    Nucleic Acids Res; 2021 Aug; 49(14):8060-8077. PubMed ID: 34289068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FUS oncofusion protein condensates recruit mSWI/SNF chromatin remodeler via heterotypic interactions between prion-like domains.
    Davis RB; Kaur T; Moosa MM; Banerjee PR
    Protein Sci; 2021 Jul; 30(7):1454-1466. PubMed ID: 34018649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SS18 together with animal-specific factors defines human BAF-type SWI/SNF complexes.
    Middeljans E; Wan X; Jansen PW; Sharma V; Stunnenberg HG; Logie C
    PLoS One; 2012; 7(3):e33834. PubMed ID: 22442726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of Atypical Acetyl-lysine Methyl Mimetics in the Development of Selective Inhibitors of the Bromodomain-Containing Protein 7 (BRD7)/Bromodomain-Containing Protein 9 (BRD9) Bromodomains.
    Clegg MA; Bamborough P; Chung CW; Craggs PD; Gordon L; Grandi P; Leveridge M; Lindon M; Liwicki GM; Michon AM; Molnar J; Rioja I; Soden PE; Theodoulou NH; Werner T; Tomkinson NCO; Prinjha RK; Humphreys PG
    J Med Chem; 2020 Jun; 63(11):5816-5840. PubMed ID: 32410449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.